References
- US FDA. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, MD, USA (2001).
- Shah VP , MidhaKK, DigheSVet al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharm. Res.9 (4), 588–592 (1992).
- Shah VP , MidhaKK, FindlayJWet al. Bioanalytical method validation – a revisit with a decade of progress. Pharm. Res.17 (12), 1551–1557 (2000).
- Shah VP , BansalS. Historical perspective on the development and evolution of bioanalytical guidance and technology. Bioanalysis3 (8), 823–827 (2011).
- US FDA. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Center for Veterinary Medicine (CVM), MD, USA (2018).
- European Medicines Agency. Guideline on Bioanalytical Method Validation. EMEA, Committee for Proprietary Medicinal Products (CPMP), London, UK (2011).
- Jemal M , OuyangZ, PowellML. A strategy for a use of incurred biological samples for establishing the acceptability of a liquid chromatography/tandem mass-spectrometric method for quantitation of drugs in biological samples. Rapid Commun. Mass Spectrom16, 1538–1547 (2002).
- Viswanathan CT , BansalS, BoothBet al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm. Res.24 (10), 1962–1973 (2007).
- Fast DM , KelleyM, ViswanathanCTet al. Workshop report and follow-up – AAPS Workshop on Current Topics in GLP Bioanalysis: assay reproducibility for incurred samples – implications of Crystal City recommendations. AAPS J.11 (2), 238–241 (2009).
- Savoie N , GarofoloF, van AmsterdamPet al. 2010 White Paper on recent issues in regulated bioanalysis and global harmonization of bioanalytical guidance. Bioanalysis2 (12), 1945–1960 (2010).
- Garofolo F , RocciM, DumontIet al. 2011 White Paper on recent issues in bioanalysis and regulatory findings from audits and inspections. Bioanalysis3 (18), 2081–2096 (2011).
- DeSilva B , GarofoloF, RocciMet al. 2012 White Paper on recent issues in bioanalysis and alignment of multiple guidelines. Bioanalysis4 (18), 2213–2226 (2012).
- Fluhler E , HayesR, GarofoloFet al. 2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1 – small molecules by LCMS). Bioanalysis6 (2), 3039–3049 (2014).
- Health Canada. Clarification of bioanalytical method validation procedures. File number: 15–110985-741 (2015). https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-clarification-bioanalytical-method-validation-procedures.html.